Dinesh V Patel Ph.D., Director, President and Chief Executive Officer, on May 12, 2026, sold 75,000 shares in Protagonist Therapeutics (PTGX) for $7,509,000. Following the Form 4 filing with the SEC, Patel has control over a total of 523,478 common shares of the company, with 523,478 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1377121/000110465926059591/xslF345X05/tm2614444-1_4seq1.xml
Thomas Peter Kalmbach, Executive Vice President & CFO, on May 08, 2026, sold 27,427 shares in Globe Life (GL) for $4,195,007. Following the Form 4 filing with the SEC, Kalmbach has control over a total of 46,486 common shares of the company, with 45,335 shares held directly and 1,152 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/320335/000032033526000173/xslF345X05/form4.xml
James D. Stein, Director, on May 08, 2026, sold 14,936 shares in South Plains Financial (SPFI) for $601,536. Following the Form 4 filing with the SEC, Stein has control over a total of 357,936 common shares of the company, with 357,936 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1163668/000212408226000003/xslF345X05/primary_doc.xml
Larry Madden, Chief Financial Officer, on May 08, 2026, sold 35,835 shares in Viant Technology (DSP) for $417,240. Following the Form 4 filing with the SEC, Madden has control over a total of 517,864 Class A common shares of the company, with 517,864 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1828791/000128430926000014/xslF345X05/wk-form4_1778621279.xml